Sequenom Inc. (NASDAQ: SQNM) design, develops, manufactures and markets innovative technology, instrumentation and tests that target and serve discovery and clinical research, and clinical molecular diagnosis markets. Technologies employed include mass spectrometry and second generation DNA sequencing. The company's proprietary MassARRAY system is a high-performance mass spectrometry based DNA analysis platform that efficiently and precisely measures the amount of genetic target material and variations.
For more information please visit : www.sequenom.com